Vascular endothelial growth factor A

Vascular endothelial growth factor A

Member of the PDGF/VEGF growth factor family

Elisa Assays For Vaccines

H19 Dye for DNA Relaxation and Supercoiling Assays

DSA1000D 1,000 assays
EUR 448.28
Description: This product includes 170 ul of 1500 x H19 dye for high throughput DNA relaxation or DNA supercoiling assays of topoisomerases.

Assay Elisa Laboratories manufactures the elisa assays for vaccines reagents distributed by Genprice. The Elisa Assays For Vaccines reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Assay elisa. Other Elisa products are available in stock. Specificity: Elisa Category: Assays Group: For Vaccines

E. coli BirA - for 100 assays

100 assays
EUR 309.4
Description: This product includes 35 ul of 5 uM E. coli BirA.

E. coli MurA - for 100 assays

100 assays
EUR 309.4
Description: This product includes 35 ul of 5 uM E. coli MurA.

E. coli MurC - for 100 assays

100 assays
EUR 309.4
Description: This product includes 35 ul of 5 uM E. coli MurC.

P. aeruginosa MurC - for 100 assays

100 assays
EUR 309.4
Description: This product includes 33 ul of 2 uM P. aeruginosa MurC.

S. pneumonia MurC - for 100 assays

100 assays
EUR 309.4
Description: This product includes 33 ul of 2 uM S. pneumoniae MurC.

E. coli MurD - for 100 assays

100 assays
EUR 309.4
Description: This product includes 35 ul of 2 uM E. coli MurD.

P. aeruginosa MurD - for 100 assays

100 assays
EUR 309.4
Description: This product includes 33 ul of 2 uM P. aeruginosa MurD.

For Vaccines information

SARS-CoV-2 Spike Trimer (XBB.1) ELISA Kit (For Vaccine Development)

RAS-A149 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike Trimer is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike S1 (B.1.1.529) Specific ELISA Kit (For Vaccine Development)

RAS-A170 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike S1 is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike RBD (B.1.1.529) Specific ELISA Kit (For Vaccine Development)

RAS-A082 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike RBD (B.1.617.2) Specific ELISA Kit (For Vaccine Development)

RAS-A092 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike RBD (BA.4 & BA.5) Specific ELISA Kit (For Vaccine Development)

RAS-A126 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike Trimer (B.1.617.2) Specific ELISA Kit (For Vaccine Development)

RAS-A055 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike Trimer (B.1.1.529) Specific ELISA Kit (For Vaccine Development)

RAS-A081 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike Trimer (BA.4) Specific ELISA Kit (For Vaccine Development)

RAS-A124 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike Trimer (BA.5) Specific ELISA Kit (For Vaccine Development)

RAS-A125 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike RBD (Wild Type) Specific ELISA Kit (For Vaccine Development)

RAS-A116 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike Trimer (Wild Type) Specific ELISA Kit (For Vaccine Development)

RAS-A115 96tests
EUR 845.3
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

Varicella Zoster Virus Glycoprotein E (VZV gE) ELISA Kit (For Vaccine Development)

RAS-A135 96tests
EUR 631.3
Description: Varicella-zoster virus (VZV) the etiologic agent of chickenpox and herpes zoster [HZ], is highly contagious and still endemic worldwide. Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of Immunogenicity in the development of VZV vaccine.Therefore,It's helpful to develop the Varicella Zoster Virus Glycoprotein E (VZV gE) ELISA Kit to quantitative detection the VZV gE antigen in vaccine samples during the manufacture and quality control of vaccine development.

HRSV (A) Pre-Fusion glycoprotein F0 Specific ELISA Kit (For Vaccine Development)

RAS-A163 96tests
EUR 845.3
Description: Respiratory syncytial virus (RSV) is a highly contagious virus causing severe infection in infants and the elderly. Various approaches are being used to develop an effective RSV vaccine. The RSV fusion (F) subunit, particularly the cleaved trimeric pre-fusion F, is one of the most promising vaccine candidates under development.A rapid and effective assay kit detecting the levels of HRSV (A) Pre-Fusion glycoprotein F0 is urgently needed to accelerate the development of RSV vaccines.

HRSV (A) Post-Fusion glycoprotein F0 Specific ELISA Kit (For Vaccine Development)

RAS-A169 96tests
EUR 845.3
Description: Most in vitro RSV neutralizing antibodies in human sera are directed against the prefusion conformation, but due to its instability the prefusion conformation has a propensity to prematurely refold into the stable postfusion conformation, both in solution and on the surface of the virions. An RSV F protein that has both high expression levels and maintains a stable prefusion conformation would, therefore, be a promising subunit vaccine candidate against RSV. To facilitate the RSV-related research, drug trials and vaccine development,a rapid and effective assay kit detecting the specific levels of HRSV (A) Post-Fusion glycoprotein F0 is urgently needed to accelerate the development of RSV vaccines.

Zika Virus (ZIKV) Envelop protein ELISA kit for vaccine testing, 48 tests, Quantitative

RV-403001-ENV-48 1 Kit
EUR 1000.8

E. coli BirA - for 100 assays

BIRA-100KEC 100 assays
EUR 309.4
Description: This product includes 35 ul of 5 uM E. coli BirA.

E. coli MurA - for 100 assays

MURA-100EC 100 assays
EUR 309.4
Description: This product includes 35 ul of 5 uM E. coli MurA.